Parkinson's Disease Trial, Recruiting (NCT06561919)

Parkinson's Disease Trial, Recruiting NCT06561919 Sponsor: Steffen Paschen Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06561919 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

The inclusion criteria for this trial are listed in the main study (STIMPulseControl KKS-313) — please confirm full details directly with the trial site.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

The exclusion criteria for this trial are listed in the main study (STIMPulseControl KKS-313) — please confirm full details directly with the trial site.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 31 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jan Rusz, Prof., Czech Technical Iniversity in Prague, Faculty of Electrical Engineering

Phone: 0049 431 500 23819

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06561919

Sponsor: Steffen Paschen

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 0049 431 500 23819

More information: https://clinicaltrials.gov/study/NCT06561919

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who may be able to join

The inclusion criteria for this trial are listed in the main study (STIMPulseControl KKS-313) — please confirm full details directly with the trial site.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

The exclusion criteria for this trial are listed in the main study (STIMPulseControl KKS-313) — please confirm full details directly with the trial site.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 31 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Steffen Paschen

Registry

ClinicalTrials.gov

Start date

5 September 2024

Est. completion

15 July 2027

Where this trial is recruiting

🇩🇪 Germany 🇳🇱 Netherlands 🇨🇭 Switzerland

Primary endpoints

Titel: PART 1: Assessment of parkinsonian motor speech features (hypokinetic dysarthria) outcome after STN-DBS; Titel PART 2: Assessment of acoustic and linguistic speech features as proxy for behavior and cognitive changes in PD; Titel PART 2: Assessment of acoustic and linguistic speech features as proxy for behavior and cognitive changes in PD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov

Who may and may not be able to join

Who may be able to join

Who may not be able to join

Contact this trial

GP referral letter

Who may be able to join

Who may not be able to join

Trial details

Where this trial is recruiting

Primary endpoints

Can't join this trial?

Expanded access pathways

Other trials for Parkinson's Disease